Mike Zaman's  Instablog

Mike Zaman
Send Message
  • (ARNA) Initiated With A Buy, (ICLD, FONR) Strong Performance On Financial Results 0 comments
    Nov 15, 2013 8:12 PM | about stocks: ICLD, ARNA, FONR

    https://staticseekingalpha.a.ssl.fastly.net/uploads/2012/11/7/saupload_arna.jpg Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

    ARNA was initiated with a Buy and price target of $9.00 by brokerage firm WallachBeth.

    ARNA closed at $5.46, up $0.35 (or +6.83%) .


    ARNA is a biopharmaceutical company focused on discovering, developing and commercializing novel-drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs.

    More about Arena Pharmaceuticals, Inc. (ARNA) at www.arenapharm.com.


    https://staticseekingalpha.a.ssl.fastly.net/uploads/2013/11/15/saupload_icld.jpg InterCloud Systems, Inc. (NASDAQ:ICLD)

    ICLD jumped $6.91 (or +270.97%) to $9.46 on Friday, after the company reported strong performance in revenue on its financial results

    For the third quarter 2013, ICLD posted revenue of $16.2 million, an increase of 448% year over year, gross profit of $5.5 million, compared to $1.2 million in the same period the prior year, and net income of $1.3 million, or $0.26 basic earnings per share, and $0.12 diluted earnings per share, compared to a net loss of $0.8 million, or ($2.16) per share, in the third quarter of 2012.


    ICLD is a global single-source provider of value-added IT and telecom solutions for both corporate enterprises and service providers.

    More about InterCloud Systems, Inc. (ICLD) at www.intercloudsys.com.


    https://staticseekingalpha.a.ssl.fastly.net/uploads/2013/11/15/saupload_fonr1.jpg FONAR Corp. (NASDAQ:FONR)

    Shares of FONR soared $6.31 (or +59.03%) to $17.00 on Friday's trading session, after the company reported a large increase in total revenues and diluted earnings per share available for the common stockholder on its financial results, compared to one year earlier.

    On its first quarter fiscal 2014, FONR posted net revenue of $16.8 million, a 77% increase year over year, income from operations of $4.0 million, compared to $1.9 million in the same period the prior year, and diluted earnings per share available for the common stockholder of $0.37, increased 68% compared to the same period one year earlier.


    FONR is engaged in the design, manufacture, sale, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, injuries, and other medical conditions

    More about FONAR Corp. (FONR) at www.fonar.com


    Read Full Disclaimer at www.drstockpick.com/disclaimer

    Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

    Stocks: ICLD, ARNA, FONR
Back To Mike Zaman's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.